ChemPartner

ChemPartner PharmaTech Co., Ltd. (Stock Abbreviation: ChemPartner, Stock Code: 300149) is driven by biotechnology innovation and focuses on pharmaceutical R&D and production service outsourcing as well as the microecological healthcare field.ChemPartner provides integrated services for medium and large pharmaceutical enterprises, biotech companies, and research institutions worldwide, covering biologics and small molecule drugs from early discovery to development and scale-up production stages. It also standardizes, refines, and manages human microecological health. The company aims to become a leading global CRO & CDMO partner and a provider of full-lifecycle integrated solutions for global pharmaceutical innovation.The company owns five national high-tech enterprises and has cultivated a leading scientific research service team with over 2,000 researchers. Headquartered in Shanghai, China, it has established research institutes, laboratories, production bases, and operational entities in the United States, Denmark, Hong Kong, Shanghai, Guangzhou, Chengdu, and Jiangmen. Its sales and service network spans across five continents globally.ChemPartner adheres to the development philosophy of "Science-based, Technology-first" and the corporate vision of "Becoming a Leading Global Innovative Service Enterprise in Pharmaceutical Healthcare." It supports innovation and upgrading in China's pharmaceutical industry, continuously empowers global pharmaceutical and healthcare innovation, and provides ongoing innovative R&D momentum for global novel drug services.